EIR REATA PHARMACEUTICALS Jul 2021

Travis Beard FDA$595.00 - Available Now

FDA investigators audited the REATA PHARMACEUTICALS - Plano, TX, United States facility and issued inspectional observation (via FDA 483) on 13 Jul 2021.

Product details

  • Category:
  • Inspection end: 13 Jul 2021
  • Location: Plano, United States
  • FEI: 3017110172
Add To Cart